Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/INVIVYD-INC-125541564/nieuws/Invivyd-kondigt-de-dosering-aan-van-de-eerste-deelnemer-aan-de-CANOPY-Fase-3-klinische-studie-die-VY-44814550/?utm_source=whatsapp&utm_medium=social&utm_campaign=share